Filing Details
- Accession Number:
- 0001104659-24-099849
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-13 17:00:11
- Reporting Period:
- 2024-09-11
- Accepted Time:
- 2024-09-13 17:00:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1504776 | Warby Parker Inc. | WRBY | Ophthalmic Goods (3851) | 800423634 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1883325 | Clive Steven Miller | C/O Warby Parker Inc., 233 Spring Street, 6Th Floor East New York NY 10013 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2024-09-11 | 6,763 | $13.90 | 177,488 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- These share sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2023.
- The price reported in Column 4 is an average execution price rounded to the nearest hundredth. These shares were sold in multiple transactions at prices ranging from $13.68 to $14.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.